UGT8 (CGT; UDP-galactose:ceramide galactosyltransferase, also called 2-hydroxyacylsphingosine 1-beta-galactosyltransferase or cerebroside synthase, EC 2.4.1.47) is a type I endoplasmic reticulum membrane glycoprotein whose catalytic domain faces the ER lumen. It transfers galactose from UDP-galactose onto ceramide, producing galactosylceramide (GalCer, a galactocerebroside) plus UDP. UGT8 galactosylates both 2-hydroxy and non-hydroxy fatty acid-containing ceramides. GalCer, and its downstream 3-O-sulfated derivative sulfatide (made by GAL3ST1), are the most abundant lipids of the myelin sheath, so UGT8 is critical for myelin formation and the differentiation of oligodendrocytes (CNS) and Schwann cells (PNS). This galactosylceramide route is a distinct, parallel branch of glycosphingolipid biosynthesis from the UGCG-dependent glucosylceramide route: UGT8 adds galactose directly to ceramide on the luminal side of the ER, whereas UGCG adds glucose to ceramide on the cytosolic face of the Golgi, and the two enzymes share no significant sequence homology.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
| GO:0003851 N-acylsphingosine galactosyltransferase activity | IBA GO_REF:0000033 | ACCEPT | Summary: Core molecular function of UGT8: transfer of galactose from UDP-galactose to ceramide to form galactosylceramide. The GO term definition matches the UniProt CGT reaction exactly. Phylogenetically inferred and well supported by orthology, experimental characterization of the rat/mouse ortholog, and UniProt catalytic activity. Supporting Evidence: file:human/UGT8/UGT8-uniprot.txt Catalyzes the transfer of galactose to ceramide, a key |
| GO:0005783 endoplasmic reticulum | IBA GO_REF:0000033 | ACCEPT | Summary: UGT8 is an ER membrane enzyme; the ER localization is well established for the protein and its orthologs. Accurate but less precise than the lumenal side of ER membrane; retained as a valid location. Supporting Evidence: file:human/UGT8/UGT8-uniprot.txt Endoplasmic reticulum |
| GO:0006682 galactosylceramide biosynthetic process | IBA GO_REF:0000033 | ACCEPT | Summary: Core biological process: UGT8 catalyzes the committed step of galactosylceramide (galactocerebroside) biosynthesis. Matches the UniProt pathway assignment (Sphingolipid metabolism; galactosylceramide biosynthesis). Supporting Evidence: file:human/UGT8/UGT8-uniprot.txt Sphingolipid metabolism; galactosylceramide biosynthesis. |
| GO:0003851 N-acylsphingosine galactosyltransferase activity | IEA GO_REF:0000120 | ACCEPT | Summary: Electronic annotation of the core catalytic activity, transferred from the rat ortholog (Q09426) and consistent with RHEA:13093 / EC 2.4.1.47. Duplicate of the IBA/ISS/Reactome annotations for the same MF; correct. Supporting Evidence: file:human/UGT8/UGT8-uniprot.txt Catalyzes the transfer of galactose to ceramide, a key |
| GO:0005783 endoplasmic reticulum | IEA GO_REF:0000120 | ACCEPT | Summary: Electronic ER localization transferred from the rat ortholog and the UniProt subcellular-location mapping. Correct. Supporting Evidence: file:human/UGT8/UGT8-uniprot.txt Endoplasmic reticulum |
| GO:0007399 nervous system development | IEA GO_REF:0000117 | KEEP AS NON CORE | Summary: GalCer/sulfatide loss in Ugt8-null mice causes dysmyelination, so UGT8 has a role in nervous system development, but this is a downstream physiological consequence of losing the myelin lipid rather than the enzyme's molecular action. Very general ARBA-predicted term; keep as a non-core process. Supporting Evidence: PMID:8661025 constituents of the myelin membrane of the central nervous system (CNS) and PNS. |
| GO:0008194 UDP-glycosyltransferase activity | IEA GO_REF:0000002 | KEEP AS NON CORE | Summary: Correct but generic InterPro-derived parent of the specific molecular function (GO:0003851). Not wrong, but subsumed by the more informative galactosyltransferase activity; keep as non-core. |
| GO:0016020 membrane | IEA GO_REF:0000044 | KEEP AS NON CORE | Summary: Correct (UGT8 is a single-pass membrane protein) but uninformative parent of the ER-membrane localization. Keep as non-core. Supporting Evidence: file:human/UGT8/UGT8-uniprot.txt Single-pass membrane |
| GO:0002175 protein localization to paranode region of axon | IEA GO_REF:0000107 | MARK AS OVER ANNOTATED | Summary: Projected electronically from the mouse ortholog (Q64676). Paranodal defects arise as a downstream consequence of GalCer/sulfatide deficiency in Ugt8-null myelin, not from a direct molecular activity of UGT8 in protein localization. Over-annotation of a lipid-biosynthetic enzyme. |
| GO:0006682 galactosylceramide biosynthetic process | IEA GO_REF:0000120 | ACCEPT | Summary: Electronic duplicate of the core galactosylceramide biosynthetic process annotation, transferred from the rat ortholog and UniPathway UPA00787. Correct. Supporting Evidence: file:human/UGT8/UGT8-uniprot.txt Sphingolipid metabolism; galactosylceramide biosynthesis. |
| GO:0007010 cytoskeleton organization | IEA GO_REF:0000107 | MARK AS OVER ANNOTATED | Summary: Projected electronically from the mouse ortholog; there is no evidence that a luminal ER galactosyltransferase acts in cytoskeleton organization. This is a spurious over-propagated term for UGT8. |
| GO:0008489 UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity | IEA GO_REF:0000107 | MODIFY | Summary: Wrong term for UGT8. GO:0008489 is the transfer of galactose onto GLUCOSYLceramide to form lactosylceramide (the B4GALT5/6 lactosylceramide-synthase reaction), not the CGT reaction. UGT8 adds galactose directly to ceramide, which is GO:0003851. This Ensembl projection conflates the two distinct galactosyltransferase reactions; modify to the correct activity term. Proposed replacements: N-acylsphingosine galactosyltransferase activity Supporting Evidence: file:human/UGT8/UGT8-uniprot.txt Catalyzes the transfer of galactose to ceramide, a key |
| GO:0030913 paranodal junction assembly | IEA GO_REF:0000107 | MARK AS OVER ANNOTATED | Summary: Projected electronically from the mouse ortholog. Paranodal junction defects are a downstream consequence of GalCer/sulfatide loss in Ugt8-null myelin, not a direct molecular function of the enzyme. Over-annotation. |
| GO:0035902 response to immobilization stress | IEA GO_REF:0000107 | MARK AS OVER ANNOTATED | Summary: Projected electronically from the rat ortholog based on a stress-response expression change. This is not a core evolved function of a lipid-biosynthetic ER enzyme and is a spurious over-propagated term for UGT8. |
| GO:0048812 neuron projection morphogenesis | IEA GO_REF:0000107 | MARK AS OVER ANNOTATED | Summary: Projected electronically from the mouse ortholog. Any effect on neuron projection morphology is an indirect consequence of altered myelin lipid composition, not a direct molecular activity of UGT8. Over-annotation. |
| GO:0006688 glycosphingolipid biosynthetic process | TAS Reactome:R-HSA-9840309 | KEEP AS NON CORE | Summary: Correct but generic parent of the specific galactosylceramide biosynthetic process (GO:0006682). GalCer is a glycosphingolipid, so this is accurate; keep as non-core in favor of the more specific process term. |
| GO:0003851 N-acylsphingosine galactosyltransferase activity | TAS Reactome:R-HSA-6785933 | ACCEPT | Summary: Reactome reaction (UGT8 transfers Gal from UDP-Gal to CERA) capturing the core catalytic activity. Consistent with all other MF annotations. Correct. |
| GO:0006688 glycosphingolipid biosynthetic process | IDA PMID:34080016 Glucosylceramide and galactosylceramide, small glycosphingol... | KEEP AS NON CORE | Summary: Experimental annotation placing UGT8 in glycosphingolipid biosynthesis. The claim is well supported (GalCer is a glycosphingolipid and UGT8 catalyzes the committed step), though the source is a review and the term is a generic parent of the specific galactosylceramide biosynthetic process. Keep as a non-core process; the specific GO:0006682 is retained as core. Supporting Evidence: PMID:34080016 This enzyme is encoded by the UGT8 gene |
| GO:0003851 N-acylsphingosine galactosyltransferase activity | ISS GO_REF:0000024 | ACCEPT | Summary: ISS transfer of the core catalytic activity from the experimentally characterized rat ortholog (Q09426). Correct; one of several duplicate MF annotations for this activity. Supporting Evidence: file:human/UGT8/UGT8-uniprot.txt Catalyzes the transfer of galactose to ceramide, a key |
| GO:0006682 galactosylceramide biosynthetic process | ISS GO_REF:0000024 | ACCEPT | Summary: ISS transfer of the core galactosylceramide biosynthetic process from the rat ortholog. Correct and consistent with the UniProt pathway assignment. Supporting Evidence: file:human/UGT8/UGT8-uniprot.txt Sphingolipid metabolism; galactosylceramide biosynthesis. |
| GO:0098553 lumenal side of endoplasmic reticulum membrane | ISS GO_REF:0000024 | ACCEPT | Summary: Most precise and biologically accurate location: UGT8 is a type I ER membrane glycoprotein whose active site faces the ER lumen, where GalCer is synthesized. Well supported by orthology and by the review literature. This is the core location. Supporting Evidence: PMID:34080016 GalCer is synthesized on the luminal side of the ER, as UGT8 is a type I membrane glycoprotein with its active site directed into the lumen of this organelle |
| GO:0005783 endoplasmic reticulum | ISS GO_REF:0000024 | ACCEPT | Summary: ISS ER localization from the rat ortholog. Correct; less precise than the lumenal side of ER membrane but a valid location. Supporting Evidence: file:human/UGT8/UGT8-uniprot.txt Endoplasmic reticulum |
| GO:0005789 endoplasmic reticulum membrane | TAS Reactome:R-HSA-6785933 | ACCEPT | Summary: Reactome localization to the ER membrane, consistent with UGT8 being a single-pass ER membrane protein. Correct. Supporting Evidence: file:human/UGT8/UGT8-uniprot.txt Single-pass membrane |
| GO:0007417 central nervous system development | TAS PMID:8661025 The human gene CGT encoding the UDP-galactose ceramide galac... | KEEP AS NON CORE | Summary: Author statement (Bosio et al. 1996) that CGT is essential for cerebroside/sulfatide synthesis in CNS myelin and important in oligodendrocyte differentiation. This is a valid but downstream developmental role reflecting the physiological importance of the myelin lipid; keep as a non-core process rather than the enzyme's molecular core. Supporting Evidence: PMID:8661025 The CGT gene therefore is important in |
| GO:0007422 peripheral nervous system development | TAS PMID:8661025 The human gene CGT encoding the UDP-galactose ceramide galac... | KEEP AS NON CORE | Summary: Author statement that CGT-derived cerebrosides/sulfatides are essential myelin constituents in the PNS (Schwann cells) as well as the CNS. Valid downstream developmental role; keep as non-core. Supporting Evidence: PMID:8661025 constituents of the myelin membrane of the central nervous system (CNS) and PNS. |
| GO:0008489 UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity | TAS PMID:8661025 The human gene CGT encoding the UDP-galactose ceramide galac... | MODIFY | Summary: Wrong molecular-function term for UGT8. GO:0008489 describes galactosylation of glucosylceramide to form lactosylceramide (the lactosylceramide-synthase reaction), whereas UGT8/CGT adds galactose directly to ceramide (GO:0003851). This is a legacy 1996 curation using an inappropriate term; modify to the correct activity. Proposed replacements: N-acylsphingosine galactosyltransferase activity Supporting Evidence: file:human/UGT8/UGT8-uniprot.txt Catalyzes the transfer of galactose to ceramide, a key |
Loading supporting content…
Download this section (compressed HTML)Q: Beyond galactosylceramide, to what extent does human UGT8 galactosylate diacylglycerol (galactosyldiacylglycerol) or other lipid acceptors in vivo, and is this physiologically significant?
Q: What is the quantitative substrate preference of human UGT8 for 2-hydroxy versus non-hydroxy fatty-acid ceramides, and does this shape the very-long-chain hydroxy-fatty-acid enrichment of myelin GalCer?
Experiment: Reconstitute purified human UGT8 in vitro with defined ceramide acceptors and UDP-galactose to measure kinetic parameters and substrate specificity across hydroxy/non-hydroxy and chain-length variants.
Experiment: Knock out UGT8 by CRISPR in a human oligodendrocyte model, then use lipidomics to confirm loss of GalCer/sulfatide and assess compensatory changes in the glucosylceramide branch.
Loading supporting content…
Download this section (compressed HTML)Loading supporting content…
Download this section (compressed HTML)